Thompson Rahsaan bought ZVRA
June 21, 2026 · Form 4 insider transaction
Thompson Rahsaan bought 66,667 shares of Zevra Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
66,667
Price
N/A
Total value
N/A
InsiderThompson Rahsaan
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 21, 2026
Filing dateJune 23, 2026
Shares owned after114,792
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.